Urological Oncology: Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology

Comment

Sam S Chang. J Urol. 2023 Jan.

. 2023 Jan;209(1):293-294.

doi: 10.1097/JU.0000000000003024. Epub 2022 Oct 21.

No abstract available

Comment on

Bacillus Calmette-Guérin Retains Clinically Relevant Viability for up to 72 Hours After Reconstitution: Potential Implications for Clinical Practice in Times of Shortage.
Brooks N, Nagaraju S, Matulay J, Han XY, Kamat AM. Brooks N, et al. Eur Urol Oncol. 2021 Oct;4(5):826-828. doi: 10.1016/j.euo.2020.03.004. Epub 2020 May 29. Eur Urol Oncol. 2021. PMID: 32475716
Social and Clinical Correlates of Neoadjuvant Chemotherapy in Medicare Beneficiaries With Muscle Invasive Bladder Cancer From 2004-2015.
Nyame YA, Holt SK, Diamontopoulos LN, Winters BR, Psutka SP, Dash A, Schade GR, Lin DW, Yu EY, Grivas P, Gore JL, Wright JL. Nyame YA, et al. Urology. 2021 Mar;149:154-160. doi: 10.1016/j.urology.2020.12.020. Epub 2020 Dec 26. Urology. 2021. PMID: 33373709